SCHEMBL9876896

SCHEMBL9876896

CCN(CC)CCCNC(=O)C(C)n1cc(-c2ccccc2)c(-c2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 2/20 0.45
ATM Q13315 1/20 0.45
GAA P10253 1/20 0.45
CYP2D6 P10635 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
THRB P10828 1/20 0.41
ACKR3 P25106 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SCN1A P35498 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9877194 0.84 ALDH1A1 (0.44) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL9877398 0.81 MEN1 (0.53) MEN1KMT2AKDM4ELMNAPOLB
SCHEMBL9877262 0.78 KDM4E (0.48) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL11620324 0.77 KMT2A (0.45) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL9877271 0.76 GFER (0.50) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL11439146 0.73 LMNA (0.52) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL9877381 0.73 L3MBTL1 (0.57) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL11620527 0.72 CCNC (0.47) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL11484379 0.72 PTGIR (0.56) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL11621977 0.72 ALDH1A1 (0.44) MEN1KMT2AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4988725-A Cardiovascular disorders, antiarrhythmia agents STERLING DRUG INC. (US) 1991-01-29 US claimed
EP-0388654-A2 Azole-1-alkanamides as antiarrhythmic agents and preparation thereof STERLING DRUG INC. (US) 1990-09-26 EP claimed
US-4988725-A Cardiovascular disorders, antiarrhythmia agents STERLING DRUG INC. (US) 1991-01-29 US disclosed
EP-0388654-A2 Azole-1-alkanamides as antiarrhythmic agents and preparation thereof STERLING DRUG INC. (US) 1990-09-26 EP disclosed
US-4916150-A 1H-pyrazole-1-alkanamines antiarrhythmic compositions and use STERLING DRUG INC. (US) 1990-04-10 US disclosed